Centre de Recherche Dermatologique de Quebec Metropolitain

Québec, Quebec G1V 4X7

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis — Stopped early
• A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis — Completed